BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/29/2026 7:26:45 AM | Browse: 2 | Download: 16
 |
Received |
|
2025-12-26 02:07 |
 |
Peer-Review Started |
|
2025-12-26 02:07 |
 |
First Decision by Editorial Office Director |
|
2026-02-02 04:06 |
 |
Return for Revision |
|
2026-02-02 04:06 |
 |
Revised |
|
2026-02-13 10:42 |
 |
Publication Fee Transferred |
|
2026-02-15 03:49 |
 |
Second Decision by Editor |
|
2026-03-09 02:46 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-09 08:03 |
 |
Articles in Press |
|
2026-03-09 08:03 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2026-05-15 01:49 |
 |
Publish the Manuscript Online |
|
2026-05-29 07:26 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Sex-specific differences in the efficacy and prognosis of 5-aminosalicylic acid therapy for ulcerative colitis: A 20-year retrospective cohort study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zhao-Shi Liu, Hao Tang, Hui-Min Zhang, Xiao-Yin Bai, Hong Yang, Xiao-Feng Li and Jia-Ming Qian |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Health Research and Special Projects Grant of China |
No. 201002020 |
| CAMS Innovation Fund for Medical Sciences |
No. 2016-I2M-3-001 |
|
| Corresponding Author |
Jia-Ming Qian, Chief Physician, MD, Professor, Department of Gastroenterology, Peking Union Medical College Hospital, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China. qianjm@pumch.cn |
| Key Words |
Ulcerative colitis; Inflammatory bowel disease; 5-aminosalicylic acid; Sex-specific differences; Efficacy; Prognosis; Endoscopic mucosal healing; Colectomy; Surgery |
| Core Tip |
Real-world data concerning sex-specific differences in the response to and long-term outcomes of 5-aminosalicylic acid (5-ASA) therapy for ulcerative colitis (UC) in large-scale UC cohorts are lacking. This retrospective study analyzed 354 patients receiving 5-ASA treatment after 1:1 propensity score matching. Male patients had an increased chance of frequent UC flare-ups, less frequent and delayed endoscopic mucosal healing, and a higher risk of surgery. These findings emphasize the need for sex-adapted therapeutic strategies to optimize 5-ASA utilization and improve individualized UC management. |
| Publish Date |
2026-05-29 07:26 |
| Citation |
Liu ZS, Tang H, Zhang HM, Bai XY, Yang H, Li XF, Qian JM. Sex-specific differences in the efficacy and prognosis of 5-aminosalicylic acid therapy for ulcerative colitis: A 20-year retrospective cohort study. World J Gastroenterol 2026; 32(22): 118036 |
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i22/118036.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i22.118036 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.